Subtopic Deep Dive

ABO Blood Group Disease Associations
Research Guide

What is ABO Blood Group Disease Associations?

ABO Blood Group Disease Associations investigate links between ABO blood group polymorphisms and risks of infectious diseases, cardiovascular conditions, and cancers via glycan-mediated mechanisms.

Research uses GWAS to identify ABO variants influencing pathogen binding, inflammation, and thrombosis. Key studies link non-O groups to higher COVID-19 severity (Zietz et al., 2020, 457 citations) and sICAM-1 levels (Paré et al., 2008, 341 citations). Over 20 papers from provided lists span infections, CVD, and oncology.

15
Curated Papers
3
Key Challenges

Why It Matters

ABO associations guide transfusion risk stratification, as non-O types show elevated vWF and hemostasis risks (Ward et al., 2020). They inform personalized medicine for COVID-19 outcomes (Hoiland et al., 2020; Goel et al., 2021) and cancer susceptibility like pancreatic (Greer, 2010) and nasopharyngeal (Sheng et al., 2013). Pleiotropic effects reveal glycan roles in disease, impacting hemoglobin response post-transfusion (Roubinian et al., 2019).

Key Research Challenges

Conflicting COVID-19 Findings

Studies show inconsistent ABO effects on infection and severity, with group O protective in some (Zietz et al., 2020; Hoiland et al., 2020) but not others (Dai, 2020). Confounders like ethnicity and testing bias complicate meta-analyses. GWAS replication across populations remains limited.

Mechanistic Pathway Gaps

ABO glycans affect vWF and ICAM-1 (Paré et al., 2008; Ward et al., 2020), but causal links to thrombosis and infection need functional validation. Glycan-pathogen binding assays are underdeveloped. Pleiotropy with CVD and cancer lacks unified models (Zhang et al., 2012).

Population Heterogeneity

Associations vary by region, e.g., nasopharyngeal cancer in Southeast China (Sheng et al., 2013) versus pancreatic cancer broadly (Greer, 2010). Rare ABO variants underrepresented in GWAS. Transfusion outcomes differ by donor-recipient matching (Roubinian et al., 2019).

Essential Papers

1.

Associations between blood type and COVID-19 infection, intubation, and death

Michael Zietz, Jason Zucker, Nicholas P. Tatonetti · 2020 · Nature Communications · 457 citations

2.

Novel Association of ABO Histo-Blood Group Antigen with Soluble ICAM-1: Results of a Genome-Wide Association Study of 6,578 Women

Guillaume Paré, Daniel I. Chasman, Mark D. Kellogg et al. · 2008 · PLoS Genetics · 341 citations

While circulating levels of soluble Intercellular Adhesion Molecule 1 (sICAM-1) have been associated with diverse conditions including myocardial infarction, stroke, malaria, and diabetes, comprehe...

3.

Testing the association between blood type and COVID-19 infection, intubation, and death

Michael Zietz, Jason Zucker, Nicholas P. Tatonetti · 2020 · 263 citations

Abstract The rapid global spread of the novel coronavirus SARS-CoV-2 has strained healthcare and testing resources, making the identification and prioritization of individuals most at-risk a critic...

4.

Human ABO Blood Groups and Their Associations with Different Diseases

Silamlak Birhanu Abegaz · 2021 · BioMed Research International · 224 citations

Introduction . Human ABO blood type antigens exhibit alternative phenotypes and genetically derived glycoconjugate structures that are located on the red cell surface which play an active role in t...

5.

Blood type biochemistry and human disease

D. Rose Ewald, Susan Sumner · 2016 · WIREs Systems Biology and Medicine · 183 citations

Associations between blood type and disease have been studied since the early 1900s when researchers determined that antibodies and antigens are inherited. In the 1950s, the chemical identification...

6.

The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19

Ryan L. Hoiland, Nicholas A. Fergusson, Anish R. Mitra et al. · 2020 · Blood Advances · 172 citations

Abstract Studies on severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) suggest a protective effect of anti-A antibodies against viral cell entry that may hold relevance for SARS-CoV-2 inf...

7.

The relationship between ABO blood group, von Willebrand factor, and primary hemostasis

Soracha E. Ward, Jamie M. O’Sullivan, James S. O’Donnell · 2020 · Blood · 158 citations

Abstract Numerous studies have reported significant associations between ABO blood group and risk of cardiovascular disease. These studies have consistently demonstrated that thrombotic risk is sig...

Reading Guide

Foundational Papers

Start with Paré et al. (2008) for inaugural ABO-ICAM-1 GWAS (341 citations), then Zhang et al. (2012) for CVD overview and Greer (2010) for cancer links to grasp genetic and phenotypic foundations.

Recent Advances

Study Zietz et al. (2020, 457 citations) and Hoiland et al. (2020) for COVID associations, Ward et al. (2020) for hemostasis, and Abegaz (2021) for broad disease synthesis.

Core Methods

GWAS for variant discovery (Paré et al., 2008), logistic regression for odds ratios in cohorts (Zietz et al., 2020), biochemical assays for vWF levels (Ward et al., 2020), and case-control for cancers (Sheng et al., 2013).

How PapersFlow Helps You Research ABO Blood Group Disease Associations

Discover & Search

Research Agent uses searchPapers and exaSearch to find ABO-COVID papers like Zietz et al. (2020), then citationGraph reveals clusters around Paré et al. (2008) GWAS, and findSimilarPapers uncovers related vWF studies (Ward et al., 2020).

Analyze & Verify

Analysis Agent applies readPaperContent to extract GWAS stats from Paré et al. (2008), verifies ABO-ICAM-1 claims via verifyResponse (CoVe), and runs PythonAnalysis for meta-analysis of COVID odds ratios from Zietz et al. (2020) and Hoiland et al. (2020) with GRADE scoring for evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in mechanistic studies beyond glycans (Ewald and Sumner, 2016), flags contradictions in COVID data, and uses exportMermaid for ABO-disease pathway diagrams; Writing Agent employs latexEditText, latexSyncCitations for Zietz et al. (2020), and latexCompile for review manuscripts.

Use Cases

"Meta-analyze ABO blood type odds ratios for COVID-19 severity from top studies."

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis with forest plots) → GRADE verification → researcher gets CSV of pooled ORs and matplotlib figures.

"Draft LaTeX review on ABO associations with pancreatic and nasopharyngeal cancer."

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Greer 2010, Sheng 2013) + latexCompile → researcher gets compiled PDF with synced bibliography.

"Find code for ABO GWAS simulations from related papers."

Research Agent → paperExtractUrls (Paré 2008) → Code Discovery → paperFindGithubRepo → githubRepoInspect → researcher gets R scripts for glycan binding models.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ ABO papers, chaining searchPapers → citationGraph → DeepScan for 7-step verification of Zietz et al. (2020) claims. Theorizer generates hypotheses on ABO-vWF-cancer pleiotropy from Ward et al. (2020) and Zhang et al. (2012), outputting Mermaid diagrams. DeepScan applies CoVe checkpoints to resolve COVID conflicts across Hoiland et al. (2020) and Dai (2020).

Frequently Asked Questions

What defines ABO Blood Group Disease Associations?

Links between ABO polymorphisms and diseases like COVID-19, CVD, cancer via glycans, identified by GWAS (Zietz et al., 2020; Paré et al., 2008).

What methods study these associations?

GWAS for genetic variants (Paré et al., 2008), cohort studies for COVID outcomes (Hoiland et al., 2020), biochemical assays for vWF (Ward et al., 2020).

What are key papers?

Zietz et al. (2020, 457 citations) on COVID; Paré et al. (2008, 341 citations) on ICAM-1; Abegaz (2021, 224 citations) review of diseases.

What open problems exist?

Causal mechanisms for pleiotropy, population-specific effects, and transfusion impacts (Roubinian et al., 2019; Sheng et al., 2013).

Research Blood groups and transfusion with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching ABO Blood Group Disease Associations with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers